Changzhou No.2 People's Hospital
Changzhou No.2 People's Hospital
Explore linked clinical trials.11 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Survey of Public Attitudes Towards Gallbladder-preserving Lithotomy and Its Influencing Factors | Digestive System Diseases, biliary tract disorder, cholecystolithiasis, cholelithiasis, gallbladder disorder | Recruiting | Not stated | 2026-10-02 | NCT07854379 | |
| Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study) | Cognition Disorders, Cognitive Dysfunction, Hemic and Lymphatic Diseases, Mild Cognitive Impairment, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, cognitive disorder, dementia, diabetes mellitus, endocrine system disorder, follicular lymphoma, glucose metabolism disease, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, metabolic disease, neoplasm, nervous system disorder, psychiatric disorder, type 2 diabetes mellitus | Recruiting | Phase 3 | 2026-09-02 | NCT07083154 | |
| Pirtobrutinib+Sonrotoclax（PS) Regimen in the Treatment of B-Cell Lymphoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Richter transformation, histiocytosis, interdigitating dendritic cell sarcoma, lymphatic system disorder, malignant histiocytosis, marginal zone lymphoma, neoplasm | Not yet recruiting | Phase 2 | 2026-08-06 | NCT07744750 | |
| Pirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, histiocytosis, interdigitating dendritic cell sarcoma, lymphatic system disorder, malignant histiocytosis, neoplasm | Not yet recruiting | Phase 2 | 2026-08-06 | NCT07744737 | |
| Pirtobrutinib+Pola-R-CHP for Newly Diagnosed Non-GCB DLBCL | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, histiocytosis, interdigitating dendritic cell sarcoma, lymphatic system disorder, malignant histiocytosis, neoplasm | Not yet recruiting | Phase 2 | 2026-08-06 | NCT07744724 | |
| A Prospective, Single-Arm, Multicenter Clinical Study of High-Risk Localized and Locally Advanced Renal Clear Cell Carcinoma | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, neoplasm, urinary system disorder | Not yet recruiting | Phase 2 | 2026-08-03 | NCT07741617 | |
| UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases | Hemic and Lymphatic Diseases, Immunoglobulin G4-Related Disease, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, Skin and Connective Tissue Diseases, anemia, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, autoimmune disorder of the nervous system, autoimmune hemolytic anemia, cardiovascular disorder, connective tissue disorder, hematologic disorder, hemolytic anemia, immune system disorder, muscle tissue disorder, musculoskeletal system disorder, myasthenia gravis, myositis disease, necrotizing vasculitis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome, skin disorder, skin vascular disease, systemic lupus erythematosus, systemic sclerosis, vascular disorder, vasculitis | Not yet recruiting | Phase 1 | 2025-05-18 | NCT06978738 | |
| Effectiveness of Multimedia Health Education to Reduce Anxiety in Patients With Vitreous Floaters | anxiety, anxiety disorder, psychiatric disorder, vitreous floaters | Recruiting | Not applicable | 2025-05-14 | NCT06964867 | |
| An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia | Thrombocytopenia Alloimmune | Recruiting | Early phase 1 | 2025-04-30 | NCT06337474 | |
| Steerable vs Conventional FANS for <2cm Lower Pole Stone Treatment: SCULPT Trial | Calculi, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Calculi, Male Urogenital Diseases, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Urinary Calculi, Urogenital Diseases, kidney disorder, nephrolithiasis, urinary system disorder, urolithiasis | Recruiting | Not applicable | 2025-03-27 | NCT06898216 | |
| FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, stomach disorder | Recruiting | Phase 2 | 2025-02-20 | NCT06405113 |